Zingiber officinale Rosc. in the Treatment of Metabolic Syndrome Disorders-A Review of In Vivo Studies

Int J Mol Sci. 2022 Dec 8;23(24):15545. doi: 10.3390/ijms232415545.

Abstract

Inflammation is a protective reaction of the innate immune system as a response to imbalances caused by a specific stimulus, a disease or a pathogen. A prolonged inflammatory condition may lead to the development of metabolic syndrome, which affects more than one-fourth of the world's population. This condition leads to the development of multi-organ disorders based on disrupted blood lipid and sugar levels, hypertension and oxidative stress. The review aims to present Zingiber officinale Rosc. as a plant that exhibits a variety of healing properties and restores the organism's equilibrium. Ginger (GI) rhizomes have been commonly used in traditional medicine to treat arthritis, stomach ache, nonalcoholic fatty liver disease, rheumatism, nervous system syndromes, asthma, diabetes and nausea caused by pregnancy or chemotherapy. This review gathers together data from in vivo experiments related to the application of ginger for the treatment of inflammatory conditions, obesity, diabetes and other related disorders as a consequence of metabolic syndrome, including the confirmed molecular mechanisms of action.

Keywords: Zingiberaceae; cardiovascular system; ginger; inflammation; molecular biology; obesity.

Publication types

  • Review

MeSH terms

  • Humans
  • Inflammation / drug therapy
  • Lipids
  • Metabolic Syndrome* / drug therapy
  • Obesity / drug therapy
  • Plant Extracts / pharmacology
  • Zingiber officinale*

Substances

  • Plant Extracts
  • Lipids